Affy to Debut Benchtop System Next Year to Reach Lower-Throughput Labs

The system, called GeneAtlas, will target "lower-throughput labs with limited capital budgets, users without access to core facilities, price-sensitive markets, and RT-PCR users looking to access whole genome," according to a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.